June 6, 2019
Roy Baynes, SVP & Head, Global Clinical Development, Chief Medical Officer, Merck Research Laboratories US pharma giant Merck was a low-key player in oncology until the acquisition of Schering-Plough a decade ago brought in a pipeline drug that is now...read more